Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 312

1.

[What do our clients want? : Is speed all that matters?]

Fronhoffs F, Thiesler T, Kristiansen G.

Pathologe. 2015 Sep 1. [Epub ahead of print] German.

PMID:
26324518
2.

Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.

Latz S, Umbach T, Goltz D, Kristiansen G, Müller SC, Ellinger J.

Urol Int. 2015 Aug 20. [Epub ahead of print]

PMID:
26287745
3.

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer.

Puhr M, Hoefer J, Eigentler A, Dietrich D, van Leenders G, Uhl B, Hoogland M, Handle F, Schlick B, Neuwirt H, Sailer V, Kristiansen G, Klocker H, Culig Z.

Oncogene. 2015 Aug 10. doi: 10.1038/onc.2015.292. [Epub ahead of print]

PMID:
26257066
4.

Novel Somatic Mutations in Primary Hyperaldosteronism are related to the Clinical, Radiological and Pathological Phenotype.

Scholl UI, Healy JM, Thiel A, Fonseca AL, Brown TC, Kunstman JW, Horne MJ, Dietrich D, Riemer J, Kücükköylü S, Reimer EN, Reis AC, Goh G, Kristiansen G, Mahajan A, Korah R, Lifton RP, Prasad ML, Carling T.

Clin Endocrinol (Oxf). 2015 Aug 7. doi: 10.1111/cen.12873. [Epub ahead of print]

PMID:
26252618
5.

Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma.

Schäfer MH, Lingohr P, Sträßer A, Lehnen NC, Braun M, Perner S, Höller T, Kristiansen G, Kalff JC, Gütgemann I.

Hum Pathol. 2015 Jun 23. pii: S0046-8177(15)00212-9. doi: 10.1016/j.humpath.2015.06.007. [Epub ahead of print]

PMID:
26239623
6.

BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma.

Nettersheim D, Jostes S, Sharma R, Schneider S, Hofmann A, Ferreira HJ, Hoffmann P, Kristiansen G, Esteller MB, Schorle H.

PLoS Genet. 2015 Jul 30;11(7):e1005415. doi: 10.1371/journal.pgen.1005415. eCollection 2015 Jul.

7.

Effect of Peripheral Artery Sympathetic Denervation on Muscle Microperfusion and Macroperfusion in an Animal Peripheral Artery Disease Model Using Contrast-Enhanced Ultrasound and Doppler Flow Measurement.

Steinberg VA, Mommertz G, Thiesler T, Kristiansen G, Schild H, Naehle CP.

J Vasc Interv Radiol. 2015 Sep;26(9):1396-1402.e2. doi: 10.1016/j.jvir.2015.06.013. Epub 2015 Jul 17.

PMID:
26190189
8.
9.

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.

Ayub TH, Keyver-Paik MD, Debald M, Rostamzadeh B, Thiesler T, Schröder L, Barchet W, Abramian A, Kaiser C, Kristiansen G, Kuhn W, Kübler K.

Oncotarget. 2015 Jun 30;6(18):16437-48.

10.

Erratum to: Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?

Branchi V, Lingohr P, Willinek WA, Bölke E, Semaan A, Zhou H, Kristiansen G, Klöppel G, Kalff JC, Schäfer N, Matthaei H.

Eur J Med Res. 2015 May 20;20:53. doi: 10.1186/s40001-015-0143-3. No abstract available.

11.

Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?

Branchi V, Lingohr P, Willinek WA, Bölke E, Semaan A, Zhou H, Kristiansen G, Klöppel G, Kalff JC, Schäfer N, Matthaei H.

Eur J Med Res. 2015 Mar 19;20:26. doi: 10.1186/s40001-015-0117-5. Erratum in: Eur J Med Res. 2015;20:53. Bölke, Edwin [added].

12.

Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.

Sailer V, Lüders C, Kuhn W, Pelzer V, Kristiansen G.

Virchows Arch. 2015 Jul;467(1):67-70. doi: 10.1007/s00428-015-1766-z. Epub 2015 Apr 8.

PMID:
25850754
13.

Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma.

Shaikhibrahim Z, Offermann A, Halbach R, Vogel W, Braun M, Kristiansen G, Bootz F, Wenzel J, Mikut R, Lengerke C, Reischl M, Schröck A, Perner S.

Am J Pathol. 2015 Apr;185(4):1114-22. doi: 10.1016/j.ajpath.2014.12.010. Epub 2015 Mar 16.

PMID:
25791637
14.

Glutathione S-transferase-pi protein expression in prostate cancer-not always a useful diagnostic tool.

Sailer V, Khov Eberhard HL, Stephan C, Wernert N, Perner S, Jung K, Dietel M, Bubendorf L, Kristiansen G.

Histopathology. 2015 Feb 12. doi: 10.1111/his.12671. [Epub ahead of print] No abstract available.

PMID:
25684637
15.

Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS.

Geisler C, Gaisa NT, Pfister D, Fuessel S, Kristiansen G, Braunschweig T, Gostek S, Beine B, Diehl HC, Jackson AM, Borchers CH, Heidenreich A, Meyer HE, Knüchel R, Henkel C.

Biomed Res Int. 2015;2015:454256. doi: 10.1155/2015/454256. Epub 2015 Jan 15.

16.

Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.

Kriebel S, Schmidt D, Holdenrieder S, Goltz D, Kristiansen G, Moritz R, Fisang C, Müller SC, Ellinger J.

PLoS One. 2015 Jan 28;10(1):e0117284. doi: 10.1371/journal.pone.0117284. eCollection 2015.

17.

Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer.

von der Emde L, Goltz D, Latz S, Müller SC, Kristiansen G, Ellinger J, Syring I.

Am J Cancer Res. 2014 Nov 19;4(6):952-62. eCollection 2014.

18.

Correlation between enhancement characteristics of MR mammography and capillary density of breast lesions.

Poellinger A, El-Ghannam S, Diekmann S, Fischer T, Kristiansen G, Fritzsche F, Fallenberg E, Morawietz L, Diekmann F.

Eur J Radiol. 2014 Dec;83(12):2129-36.

PMID:
25445895
19.

Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications.

Matthaei H, Lingohr P, Strässer A, Dietrich D, Rostamzadeh B, Glees S, Roering M, Möhring P, Scheerbaum M, Stoffels B, Kalff JC, Schäfer N, Kristiansen G.

Virchows Arch. 2015 Feb;466(2):133-41. doi: 10.1007/s00428-014-1689-0. Epub 2014 Nov 26.

PMID:
25425476
20.

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer -what has gone wrong? A blueprint for the way forward in biomarker studies.

Huber F, Montani M, Sulser T, Jaggi R, Wild P, Moch H, Gevensleben H, Schmid M, Wyder S, Kristiansen G.

Br J Cancer. 2015 Jan 6;112(1):140-8. doi: 10.1038/bjc.2014.588. Epub 2014 Nov 25.

PMID:
25422912
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk